|
Local Law Firms Home > Product Liability Overview > Class Action > Yasmin Pulmonary Embolism The Food and Drug Administration has reported that it has received new facts about the potential hazards of birth control products, such as Yasmin, and others that contain drospirenone and will conduct a review to examine these findings. The FDA said this report will further assess the dangers of blood clots in patients who take these products. The administration noted it is aware of two recently published reports that evaluated the possibility of venous thromboembolism (VTE) in patients who take birth control pills that contain drospirenone. The two newly published reports looked at whether there is a higher chance of blood clots in women taking birth control products containing the progestin drospirenone in comparison to similar patients taking birth control pills containing a different ingredient known as levonorgestrel. Have you or a loved one been injured by the birth control Yasmin? A Yasmin lawyer can help! You may able to recover monetary compensation in a class action lawsuit. Contact a Yasmin attorney in your area today for more information.
According to the FDA, manufacturers of Yasmin must alter all promotional material in accordance to the FDA mandated label modification. Marketing material must include facts on the dangers of thromboembolism in patients using Yasmin compared to contraceptives using other ingredients and chemicals. Did you know? These complications were seen to be especially common among women who had used Yasmin and had any type of history involving heart issues. There are also other health problems that have been linked to increased dangers with the use of Yasmin. |